No abstract

vascular disease) affecting therapyial preliminary considerations of dental implant treatment. However, in case of HIV-positive patients, the dental implant failure rate would not increase due to affective factors (e.g., prophylactic antibiotic treatment, the administration of active antiretroviral therapy, and control of the CD 4+ T lymphocyte counts). Therefore, these patients have no clinical signs of mobility or infection in this treatment and much more attention should be paid to these patients and they should be treated with controlled oral surgical procedures.

No abstract

No abstract